Published in Acta Neuropathol Commun on April 26, 2016
Mechanisms of Autoantibody-Induced Pathology. Front Immunol (2017) 0.76
Marked central nervous system pathology in CD59 knockout rats following passive transfer of Neuromyelitis optica immunoglobulin G. Acta Neuropathol Commun (2017) 0.75
A simple method for organotypic cultures of nervous tissue. J Neurosci Methods (1991) 14.18
Intra-cerebral injection of neuromyelitis optica immunoglobulin G and human complement produces neuromyelitis optica lesions in mice. Brain (2010) 3.95
A regenerative approach to the treatment of multiple sclerosis. Nature (2013) 3.42
An open label study of the effects of rituximab in neuromyelitis optica. Neurology (2005) 2.99
Aquaporin 4 and neuromyelitis optica. Lancet Neurol (2012) 2.58
Drug-based modulation of endogenous stem cells promotes functional remyelination in vivo. Nature (2015) 2.47
Eculizumab in AQP4-IgG-positive relapsing neuromyelitis optica spectrum disorders: an open-label pilot study. Lancet Neurol (2013) 2.46
Anti-aquaporin-4 monoclonal antibody blocker therapy for neuromyelitis optica. Ann Neurol (2012) 2.45
Micropillar arrays as a high-throughput screening platform for therapeutics in multiple sclerosis. Nat Med (2014) 2.36
Pivotal role of choline metabolites in remyelination. Brain (2014) 2.22
Aquaporin water channels in the nervous system. Nat Rev Neurosci (2013) 2.10
Retinoid X receptor gamma signaling accelerates CNS remyelination. Nat Neurosci (2010) 1.84
Oligodendrocyte precursors migrate along vasculature in the developing nervous system. Science (2016) 1.80
Inhibition of Notch signaling enhances tissue repair in an animal model of multiple sclerosis. J Neuroimmunol (2005) 1.76
Ex vivo spinal cord slice model of neuromyelitis optica reveals novel immunopathogenic mechanisms. Ann Neurol (2011) 1.72
Treatment of neuromyelitis optica: state-of-the-art and emerging therapies. Nat Rev Neurol (2014) 1.53
Myelin-mediated inhibition of oligodendrocyte precursor differentiation can be overcome by pharmacological modulation of Fyn-RhoA and protein kinase C signalling. Brain (2009) 1.49
Oligodendrocytes are damaged by neuromyelitis optica immunoglobulin G via astrocyte injury. Brain (2010) 1.42
ERK1/ERK2 MAPK signaling is required to increase myelin thickness independent of oligodendrocyte differentiation and initiation of myelination. J Neurosci (2012) 1.30
Neuromyelitis optica IgG and natural killer cells produce NMO lesions in mice without myelin loss. Acta Neuropathol (2012) 1.28
Rituximab dosing and monitoring strategies in neuromyelitis optica patients: creating strategies for therapeutic success. Mult Scler (2012) 1.26
Eosinophil pathogenicity mechanisms and therapeutics in neuromyelitis optica. J Clin Invest (2013) 1.12
Endogenous glucocorticoids improve myelination via Schwann cells after peripheral nerve injury: An in vivo study using a crush injury model. Glia (2010) 1.00
Fyn tyrosine kinase regulates oligodendroglial cell development but is not required for morphological differentiation of oligodendrocytes. J Neurosci Res (2001) 0.99
Identification of select glucocorticoids as Smoothened agonists: potential utility for regenerative medicine. Proc Natl Acad Sci U S A (2010) 0.97
The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors. Exp Neurol (2003) 0.97
Biology of AQP4 and anti-AQP4 antibody: therapeutic implications for NMO. Brain Pathol (2013) 0.96
Unique neuromyelitis optica pathology produced in naïve rats by intracerebral administration of NMO-IgG. Acta Neuropathol (2013) 0.95
Early loss of oligodendrocytes in human and experimental neuromyelitis optica lesions. Acta Neuropathol (2013) 0.94
Isolation of cortical mouse oligodendrocyte precursor cells. J Neurosci Methods (2012) 0.93
A selective thyroid hormone β receptor agonist enhances human and rodent oligodendrocyte differentiation. Glia (2014) 0.93
C1q-targeted monoclonal antibody prevents complement-dependent cytotoxicity and neuropathology in in vitro and mouse models of neuromyelitis optica. Acta Neuropathol (2013) 0.92
Multiple functional therapeutic effects of the estrogen receptor β agonist indazole-Cl in a mouse model of multiple sclerosis. Proc Natl Acad Sci U S A (2014) 0.87
Genetic activation of Hedgehog signaling unbalances the rate of neural stem cell renewal by increasing symmetric divisions. Stem Cell Reports (2014) 0.86
Remyelination in multiple sclerosis: cellular mechanisms and novel therapeutic approaches. J Neurosci Res (2014) 0.86
Olesoxime accelerates myelination and promotes repair in models of demyelination. Ann Neurol (2012) 0.85
Inhibition of LINGO-1 promotes functional recovery after experimental spinal cord demyelination. Exp Neurol (2015) 0.85
Promoting remyelination in multiple sclerosis: current drugs and future prospects. Mult Scler (2015) 0.85
Megalin mediates the influence of sonic hedgehog on oligodendrocyte precursor cell migration and proliferation during development. Glia (2012) 0.83
Combination of cyclosporine A with corticosteroids is effective for the treatment of neuromyelitis optica. J Neurol (2012) 0.83
Glucocorticoid hedgehog agonists in neurogenesis. Vitam Horm (2011) 0.83
Induction of oligodendrocyte differentiation and in vitro myelination by inhibition of rho-associated kinase. ASN Neuro (2014) 0.82
Quetiapine fumarate for the treatment of multiple sclerosis: focus on myelin repair. CNS Neurosci Ther (2013) 0.81
TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1. Glia (2014) 0.79
Anti-aquaporin-4 antibodies in neuromyelitis optica: how to prove their pathogenetic relevance? Int MS J (2008) 0.79
Remyelination Therapy in Multiple Sclerosis. Front Neurol (2015) 0.79
Involvement of glucocorticoid receptor activation on anti-inflammatory effect induced by peroxisome proliferator-activated receptor γ agonist in mice. Int Immunopharmacol (2014) 0.79
Clobetasol and Halcinonide Act as Smoothened Agonists to Promote Myelin Gene Expression and RxRγ Receptor Activation. PLoS One (2015) 0.78
Enprofylline protects motor neurons from in vitro excitotoxic challenge. Neurodegener Dis (2005) 0.78
Multiple Antenatal Dexamethasone Treatment Alters Brain Vessel Differentiation in Newborn Mouse Pups. PLoS One (2015) 0.76